Are you Dr. Sun?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 12 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3601 W 13 Mile Rd
Royal Oak, MI 48073Phone+1 248-898-1994Fax+1 947-522-0307
Summary
- Dr. Jihong Sun, MD is a board certified pathologist in Royal Oak, Michigan. She is currently licensed to practice medicine in Michigan, Pennsylvania, and New Jersey. She is affiliated with Mount Sinai Morningside, The Mount Sinai Hospital, and Mount Sinai Beth Israel.
Education & Training
- University of Louisville School of MedicineFellowship, Cytopathology, 2014 - 2015
- Indiana University School of MedicineResidency, Pathology-Anatomic and Clinical, 2010 - 2014
- Beijing Medical UniversityClass of 1991
Certifications & Licensure
- NY State Medical License 2015 - 2027
- MI State Medical License 2023 - 2026
- PA State Medical License 2023 - 2026
- NJ State Medical License 2021 - 2025
- KY State Medical License 2014 - 2021
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 4 citationsMelanotic medullary thyroid carcinoma: A case report with review of the literature.Katarzyna A Brzezinska, Swati Bhardwaj, Marita S Teng, Qiusheng Si, Jihong Sun
Diagnostic Cytopathology. 2023-01-01 - 21 citationsWell-Differentiated Laryngeal/Hypopharyngeal Liposarcoma in the MDM2 Era Report of Three Cases and Literature ReviewHui Zhu, Jihong Sun, Shi Wei, Diping Wang, Margaret S. Brandwein
Head and Neck Pathology. 2017-06-01 - 8 citationsSignet-ring cell lymphoma: clinicopathologic, immunohistochemical, and fluorescence in situ hybridization studies of 7 casesShanxiang Zhang, Jihong Sun, Yanan Fang, Mehdi Nassiri, Lanting Liu
Annals of Diagnostic Pathology. 2017-02-01
Press Mentions
- Magnetic Resonance Colonography with Intestine-Absorbable Nanoparticle Contrast Agents in Evaluation of Colorectal InflammationJanuary 6th, 2021